Cancer Treatment Centers of America has partnered with the companies Allscripts and NantHealth to create a custom, comprehensive oncology treatment platform called Clinical Pathways. The platform allows oncologists to be able to provide patients with evidence-based treatment regimens based on the integration of Allscripts Sunrise and eviti® platform that’s the first-of-it’s kind. The Clinical Pathways program provides information which can improve the treatment process without interrupting clinical workflow. The Nantos system contains comprehensive evolving cancer care data from hundreds of oncologists nationwide.
As stated on webmd.com, the Clinical Pathways system is patient-centered and offers all appropriate treatment options. This takes the guesswork out of clinical oncology treatment by presenting customized treatment options that are safe and efficient. It integrates the latest data, complementary therapies and treatment regimens into Allscripts Sunrise EHR. This helps to optimize the quality of life of patients receiving cancer treatment while meeting their unique needs. It also provides more transparency about therapeutic selections and the delivery of care and improves treatment strategies and outcomes.
Cancer Treatment Centers of America is a Boca Raton, Florida based company. It serves adult cancer patients through a network of five hospitals nationwide. The company is known for its integrative approach to cancer care. It combines genomic testing, chemotherapy, immunotherapy, radiation, surgery and precision cancer treatment with supportive therapies which enhance the patients quality of life by helping them physically and emotionally. This approach helps manage side effects which can appear during and after treatment.
CTCA treats international patients at their hospitals in Tulsa, Phoenix, Philadelphia, Chicago and Atlanta. The CTCA facilities are considered among the best U.S. hospitals for the delivery of quality care and an excellent patient experience. The CTCA facilities provides patients and their loved ones with comprehensive information related to treatment options and encourages them to actively participate in treatment decisions.
For more information follow CTCA on Twitter.